​

Obesity treatment is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include zealand pharma's petrelintide shows 9.2% weight loss in phase 2 obesity trial, man who weighed 49 stone loses 32 stone after doctor's warning during heart surgery, eli lilly's retatrutide achieves up to 30% weight loss in phase 3 triumph-1 trial, among other significant events and policy changes.

Source: Geo Health Space